Skip to main content
Completed Studies
  1. Home
  2. Studies
  3. Completed Studies

This is the list of all of the completed studies.

Clear

19-001 - NRG-HN002: A Randomized Phase II Trial for patients with p16-Positive, Non-Smoking-Associated, Locoregionally Advances Oropharyngeal Cancer

Chief Investigator(s): Sue S Yom

Contact Email: sue.yom@ucsf.edu

Acronym: NRG-HN002

Lead Committee: Young Investigators Committee (YIC)

Study Type: Phase 2 RCT

Population: Curative

Tumour Type: OSCC

Status: Published

18-003 - Delineation of primary Tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma…consensus guidelines

Chief Investigator(s): Vincent Gregoire

Contact Email: Vincent.GREGOIRE@lyon.unicancer.fr

Lead Committee: Guidelines and Protocol Committee (G&PC)

Study Type: Delphi

Population: Curative

Tumour Type: HNSCC

Status: Published

18-002 - Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non- inferiority trial

Chief Investigator(s): Maura L Gillison, Andy M Trotti

Contact Email: mgillison@mdanderson.org

Acronym: RTOG 1016

Lead Committee: Scientific Clinical Trials Committee (SCTC)

Study Type: Phase 3 RCT

Population: Curative

Tumour Type: HPV OPC

Status: Published

18-001 - Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer HNCIG (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Chief Investigator(s): Hisham Mehanna

Contact Email: h.mehanna@bham.ac.uk

Acronym: De-ESCALaTE

Lead Committee: Scientific Clinical Trials Committee (SCTC)

Study Type: Phase 3 RCT

Population: Curative

Tumour Type: HPV OPC

Status: Published